Researchers at the Department of Obstetrics and Gynecology of the Medical Center — University of Freiburg have developed an approach for detecting breast cancer by means of urine samples that is highly accurate
The method involves determining the concentration of molecules that regulate cell metabolism and that are often dysregulated in cancer cells. These molecules, referred to as microRNAs, enter into the urine over the blood. By determining the composition of microRNAs in the urine, the scientists succeeded in establishing with 91 percent accuracy whether a test subject was healthy or diseased.
The measurement was possible through the detection of only four microRNAs. If the effectiveness of the method is confirmed in further studies, it could serve in the future as a means of monitoring the success of treatment and potentially also of making an early diagnosis of breast cancer.
The Freiburg scientists published their findings in the journal BMC Cancer and have applied for a patent for the method.
About 1.7 million women suffer from breast cancer worldwide. It is the most common type of tumor in women. The disease claims more than 520 thousand lives each year. Up to now, doctors have made the diagnosis by mammography or ultrasound and confirmed it with tissue samples. However, these methods have been subject to recurring criticism due to radiation exposure, erroneous results, and the fact that they involve an invasive intervention.
Experimental test already highly accurate
Prof. Dr. Elmar Stickeler, medical director of Senology at the Department of Obstetrics and Gynecology and head of the Breast Center at the Medical Center — University of Freiburg, and his team have now developed a urine test capable of detecting tumors on the basis of changes in metabolism. The researchers measured the concentrations of nine microRNAs in the urine, short genetic sequences that regulate cell metabolism. Four of the nine molecules exhibited significant differences in concentration between healthy and diseased test subjects.
“We discovered that the microRNA profile in the urine is modified in a characteristic way in the urine of test subjects with breast cancer,” says Prof. Stickeler. “MicroRNAs should thus be suitable in principle for a breast cancer test.” With the help of the microRNA profiles, the researchers were able to determine with 91 percent accuracy whether a test subject was healthy or diseased. “Our method therefore led to highly accurate diagnoses,” says Prof. Stickeler.
The study included 24 healthy test subjects and 24 women who had recently been diagnosed with a breast tumor. The patients were in tumor stages 1, 2, or 3. It will now be necessary to conduct further studies to confirm the effectiveness of the method with larger groups of patients.
The Latest on: Breast Cancer
via Google News
The Latest on: Breast Cancer
- MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Canceron July 9, 2020 at 5:08 pm
MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal.
- RHOBH: Kyle Richards Fears for Kim as She Has Implants Removed — 'I Lost My Mom to Breast Cancer'on July 9, 2020 at 3:01 pm
During Wednesday night's episode of RHOBH, Kim Richards had her breast implants removed after one of them "deflated" ...
- Expansion stress enhances growth and migration of breast cancer cellson July 9, 2020 at 1:17 pm
Expansion stress can have an alarming impact on breast cancer cells by creating conditions that could lead to dangerous acceleration of the disease, an interdisciplinary team of University of Alabama ...
- Breast cancer cells can reprogram natural killer cells to aid in metastasison July 9, 2020 at 9:59 am
Natural killer cells, a type of immune cell, are known to limit metastasis by inducing the death of cancer cells. But metastases still form in patients, so there must be ways for cancer cells to ...
- Breast cancer cells can reprogram immune cells to assist in metastasison July 9, 2020 at 7:36 am
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of ...
- Preventing breast cancer metastasis by reactivating natural killer immune cellson July 9, 2020 at 7:19 am
One key component of the immune system that prevents breast cancer cells from forming distant metastases is a group of cells called natural killer cells. How breast tumor cells evade this surveillance ...
- Breast cancer cells could one day be manipulated to help treat tumourson July 9, 2020 at 7:00 am
One in eight women in the UK and US will develop breast cancer at some point in their life. () Breast cancer cells could one day be manipulated to actually treat tumou ...
- Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challengeson July 9, 2020 at 5:31 am
Colon cancer inter-tumour heterogeneity is installed on multiple levels, ranging from (epi)genetic driver events to signalling pathway rewiring reflected by differential gene expression patterns.
- Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathwayon July 9, 2020 at 2:48 am
Breast cancer is considered to be the most prevalent cancer in women worldwide, and metastasis is the primary cause of death. Protease-activated receptor 1 (PAR1) is a GPCR family member involved in ...
- Breast cancer simulation models can guide screening recommendations for womenon July 8, 2020 at 10:43 pm
Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metastases in various solid tumors.
via Bing News